共 7 条
Inhibition of a C-rich oligodeoxynucleotide on activation of immune cells in vitro and enhancement of antibody response in mice
被引:22
|作者:
Yang, Guang
[1
]
Wan, Min
[1
]
Zhang, Yongsheng
[1
]
Sun, Luguo
[1
]
Sun, Ran
[2
]
Hu, Dali
[2
]
Zhou, Xiaojing
[1
]
Wang, Li
[2
]
Wu, Xiuli
[1
]
Wang, Liying
[1
]
Yu, Yongli
[2
]
机构:
[1] Jilin Univ, Dept Mol Biol, Med Coll Norman Bethune, Changchun 130021, Peoples R China
[2] Jilin Univ, Dept Immunol, Med Coll Norman Bethune, Changchun 130021, Peoples R China
来源:
关键词:
antibody;
autoimmune disease;
suppressive oligodeoxynucleotides;
toll like receptor;
type I interferon;
SYSTEMIC-LUPUS-ERYTHEMATOSUS;
TOLL-LIKE RECEPTOR-9;
ANTIGEN-PRESENTING CELLS;
BACTERIAL-DNA;
CPG MOTIFS;
AUTOANTIBODY PRODUCTION;
AUTOIMMUNE-DISEASE;
INTERFERON-ALPHA;
IFN-ALPHA;
B-CELLS;
D O I:
10.1111/j.1365-2567.2010.03322.x
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
To explore the possibility that human mitochondrial genomic DNA-mimicking oligodeoxynucleotides could regulate the immune response, a series of mitochondrial DNA-based oligodeoxynucleotides (MTODNs) were designed and studied to determine their immunoregulatory effects on immune cells activated by toll-like receptor (TLR) stimulation. The results showed that a C-rich MTODN, designated MT01, was able to inhibit the proliferation of human peripheral blood mononuclear cells (PBMCs) induced by cytosine-phosphate-guanosine (CpG) oligodeoxynucleotides (ODNs) and the production of type I interferon (IFN) from human PBMCs stimulated by TLR agonists, including inactivated influenza virus, imiquimod, inactivated herpes simplex virus-1 (HSV-1) and CpG ODNs. In addition, MT01 inhibited the CpG ODN-enhanced antibody response and this inhibition could be related to the antagonism of TLR9-activation pathways in B cells. Notably, unlike the G-rich suppressive ODNs reported, MT01 is composed of ACCCCCTCT repeats. These data imply that MT01 represents a novel class of immunosuppressive ODNs that could be candidate biologicals with therapeutic use in TLR activation-associated diseases.
引用
收藏
页码:501 / 512
页数:12
相关论文